We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

58 hedge funds and large institutions have $49.5M invested in Adverum Biotechnologies in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more capital invested

Capital invested by funds: $32.5M → $49.5M (+$16.9M)

13% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 15

0.1% more ownership

Funds ownership: 3.04% → 3.14% (+0.1%)

8% less funds holding

Funds holding: 63 → 58 (-5)

33% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 12

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $19K

Holders
58
Holders Change
-5
Holders Change %
-7.94%
% of All Funds
1.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
17
Reduced
15
Closed
12
Calls
–
Puts
$19K
Net Calls
-$19K
Net Calls Change
-$6K

Top Buyers

Rank Fund Capital Flow
1
SC
Sessa Capital
New York
+$1.3M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.16M
3
MP
Mangrove Partners
Connecticut
+$1.15M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$988K
5
TCM
Tekla Capital Management
Massachusetts
+$833K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$947K
2
NI
Numeric Investors
Massachusetts
-$804K
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$654K
4
AIC
AWM Investment Company
New York
-$500K
5
Goldman Sachs
Goldman Sachs
New York
-$420K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jacobs Levy Equity Management
26
Jacobs Levy Equity Management
New Jersey
$335K +$26.9K +970 +12%
PAM
27
Panagora Asset Management
Massachusetts
$310K -$65.5K -2,361 -22%
Two Sigma Investments
28
Two Sigma Investments
New York
$274K +$35.2K +1,268 +20%
Russell Investments Group
29
Russell Investments Group
United Kingdom
$241K +$183K +6,600 New
Northern Trust
30
Northern Trust
Illinois
$195K +$59K +2,127 +66%
SIM
31
Spark Investment Management
New York
$148K +$113K +4,070 New
Bank of New York Mellon
32
Bank of New York Mellon
New York
$141K – – –
ECM
33
Element Capital Management
New York
$129K -$248K -8,936 -72%
HCM
34
Highbridge Capital Management
New York
$121K – – –
Squarepoint
35
Squarepoint
New York
$116K +$59.7K +2,150 +209%
Jane Street
36
Jane Street
New York
$108K +$82.3K +2,967 New
MAM
37
Marquette Asset Management
Minnesota
$95K – – –
RG
38
Redmile Group
California
$81K – – –
JMPWA
39
JP Morgan Private Wealth Advisors
California
$73K – – –
Simplex Trading
40
Simplex Trading
Illinois
$57K +$43.3K +1,562 +9,763%
WCM
41
Wildcat Capital Management
New York
$55K – – –
VF
42
Virtu Financial
New York
$53K +$40.5K +1,458 New
SCM
43
Stevens Capital Management
Pennsylvania
$42K -$15.9K -574 -33%
Citadel Advisors
44
Citadel Advisors
Florida
$37K +$28.2K +1,015 New
IA
45
IFP Advisors
Florida
$22K – – –
Group One Trading
46
Group One Trading
Illinois
$21K -$2.83K -102 -15%
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$21K +$56 +2 +0.4%
Barclays
48
Barclays
United Kingdom
$16K -$304K -10,953 -96%
TRCT
49
Tower Research Capital (TRC)
New York
$13K +$1.67K +60 +20%
AG
50
Advisor Group
Arizona
$7K – – –
1
2
3

ADVM Hedge Fund Activity: Q3 2017 in Review

58 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q3 2017, worth a combined $49.5M — up 52% from $32.5M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ADVM and 8 opened new positions — a net loss of 4 holders — while 15 trimmed existing stakes and 17 added.

The largest buyer was Sessa Capital, adding an estimated $1.3M. The largest seller was Millennium Management, cutting an estimated $947K.

  • 58 institutional investors held Adverum Biotechnologies (ADVM) as of Q3 2017, down from 63 in Q2 2017.
  • Funds reported $49.5M of Adverum Biotechnologies stock for Q3 2017, up 52% quarter-over-quarter.
  • 8 funds opened new Adverum Biotechnologies positions in Q3 2017 and 12 closed out, a net change of -4 holders.
  • The largest Adverum Biotechnologies buyer in Q3 2017 was Sessa Capital, an estimated $1.3M added.
  • The largest Adverum Biotechnologies seller in Q3 2017 was Millennium Management, an estimated $947K sold.

Based on aggregated 13F filings for Q3 2017.